OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Public Statements

Office

Presidential Congressional Gubernatorial State Legislative Federal Judicial Statewide State Judicial

State

Alabama Alaska American Samoa Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana National Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Northern Mariana Islands Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virgin Islands Virginia Washington West Virginia Wisconsin Wyoming

Issue

All Issues Abortion Agriculture and Food Animals and Wildlife Arts, Entertainment, and History Budget, Spending and Taxes Business and Consumers Business, Consumers, and Employees Campaign Finance Civil Liberties and Civil Rights Conservative Constitution Criminal Justice Death Penalty Defense Drugs Economy and Fiscal Education Elections Employment and Affirmative Action Energy Entitlements and the Safety Net Environment Executive Branch Family Federal, State and Local Relations Finance and Banking Fiscally Conservative Fiscally Liberal Food Processing and Sales Foreign Affairs Foreign Aid Gambling and Gaming Government Budget and Spending Government Operations Guns Health Insurance Health and Health Care High Priority Higher Education Housing and Property Ideology Immigration Impartial/Nonpartisan Indigenous Peoples Industries Infrastructure Issues Judicial Branch K-12 Education Labor Unions Legal Legislative Branch Liberal Low Priority Marijuana Marriage Military Personnel Minors and Children Monetary Policy National Security Natural Resources Oil and Gas Populations Priorities Religion Reproduction Science Science, Technology and Communication Senior Citizens Sexual Orientation and Gender Identity Social Socially Conservative Socially Liberal Stem Cell Research Taxes Technology and Communication Trade Transportation Unemployed and Low-Income Veterans Women

Limit results to:

Date Range

Keyword Search

Search string must be longer than 3 characters.
Page 2 of 16
results per page:
75 50 25
Date Title Politician
April 11, 2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter Sen. Amy Klobuchar, ...
April 10, 2022 Tweet - "I hear from Minnesotans all the time about the impossible choices they have to make--refill a prescription or pay the water bill? Get insulin or buy groceries? No one should be forced to make these decisions. Congress must take action to lower prescription drug costs." Sen. Amy Klobuchar
April 2, 2022 Tweet - "Still true!" Sen. Amy Klobuchar
April 2, 2022 Tweet - "Thank you, @RepAngieCraig , for your important work on this bill. I'm proud to cosponsor it in the Senate and am ready to work to get it passed! Let's get it done." Sen. Amy Klobuchar
April 1, 2022 Tweet - "We must cap the price of insulin at $35 per month." Sen. Amy Klobuchar
March 29, 2022 Tweet - "Capping the cost of insulin at $35 per month just makes sense." Sen. Amy Klobuchar
March 28, 2022 Tweet - "A friendly reminder that the fight to lower prescription drug costs continues." Sen. Amy Klobuchar
March 23, 2022 Tweet - "Americans should not have to choose between risking their lives or financial ruin because of the unaffordable costs of long available drugs like insulin -- especially as drug manufacturers increase their revenues from insulin sales." Sen. Amy Klobuchar
March 19, 2022 Tweet - "A system that allows Americans to pay 250% more for prescription drugs than people in other industrialized nations is just not a system that's working for the American people." Sen. Amy Klobuchar
March 17, 2022 Klobuchar, Colleagues Introduce Legislation to Cap Insulin Costs Sen. Amy Klobuchar
March 17, 2022 Tweet - "Americans pay more for prescription drugs than any other developed country. That is unacceptable. I will never stop fighting to lower prescription drug costs." Sen. Amy Klobuchar
March 16, 2022 Schakowsky, Warren, Klobuchar, Porter, Colleagues Call Out Drug Manufacturers For Providing Misleading Information on High Drug Prices Sen. Amy Klobuchar, ...
March 15, 2022 Tweet - "I'm proud to support capping the price of insulin at $35. Who's with me?" Sen. Amy Klobuchar
March 10, 2022 Tweet - "Remember Joshua from the State of the Union? We need to cap insulin costs at $35 for him." Sen. Amy Klobuchar
March 10, 2022 Letter to Robert Califf, Commissioner of the U.S. Food and Drug Administration - Romney, Durbin Lead Colleagues in Urging FDA to Regulate E-Cigarettes after Six Month Delay Sen. Tina Smith, ...
March 9, 2022 Tweet - "Want to hear something crazy? The average American spends more than $1300/year on prescription drugs. That's more than in any other country in the world. That has to change." Sen. Amy Klobuchar
March 1, 2022 Letter to Stephen J. Ubl, President and CEO of PhRMA - Senator Baldwin, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs Sen. Tina Smith, ...
Feb. 17, 2022 Letter to Hon. Xavier Becerra, Secretary of Health and Human Services, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease, and Dr. Lawrence A. Tabak, Acting Director of the National Institutes of Health - Foster Leads Bipartisan Call to Accelerate Research of COVID-19 Combination Therapies Rep. Angie Craig, ...
Feb. 14, 2022 Letter to Hon. Joseph Biden, President of the United States of America - CONGRESSMAN VALADAO URGES BIDEN TO TAKE ACTION TO COMBAT FENTANYL EPIDEMIC Rep. Pete Stauber, ...
Feb. 12, 2022 Tweet - "We can no longer tolerate policies that make prescription drugs unaffordable and out-of-reach.   Congress must act.   Every day that goes by without implementing meaningful reform is a day too long." Sen. Amy Klobuchar
Feb. 11, 2022 Letter to Joseph R. Biden, President of the United States - Joyce Urges the President to Address Threat of Fentanyl-Related Substances Flooding into American Communities Rep. Michelle Fischbach, ...
Feb. 10, 2022 Emmer Joins 116 Republicans on a Letter Demanding Biden Take Action on Fentanyl Rep. Tom Emmer
Feb. 9, 2022 Tweet - "NOW: @SenSanders and I are speaking on the Senate floor about the urgent need to lower the cost of prescription drugs. Last month alone, drug companies hiked the prices of 742 drugs in the U.S. It is past time for Congress to act." Sen. Amy Klobuchar
Jan. 26, 2022 Tweet - "Still true!" Sen. Amy Klobuchar
Jan. 21, 2022 Tweet - "It's simple: we need to reform the system so Americans can get the drugs they need at prices they can afford." Sen. Amy Klobuchar
Date Title Politician
April 11, 2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter Sen.Amy Klobuchar, ...
April 10, 2022 Tweet - "I hear from Minnesotans all the time about the impossible choices they have to make--refill a prescription or pay the water bill? Get insulin or buy groceries? No one should be forced to make these decisions. Congress must take action to lower prescription drug costs." Sen.Amy Klobuchar
April 2, 2022 Tweet - "Still true!" Sen.Amy Klobuchar
April 2, 2022 Tweet - "Thank you, @RepAngieCraig , for your important work on this bill. I'm proud to cosponsor it in the Senate and am ready to work to get it passed! Let's get it done." Sen.Amy Klobuchar
April 1, 2022 Tweet - "We must cap the price of insulin at $35 per month." Sen.Amy Klobuchar
March 29, 2022 Tweet - "Capping the cost of insulin at $35 per month just makes sense." Sen.Amy Klobuchar
March 28, 2022 Tweet - "A friendly reminder that the fight to lower prescription drug costs continues." Sen.Amy Klobuchar
March 23, 2022 Tweet - "Americans should not have to choose between risking their lives or financial ruin because of the unaffordable costs of long available drugs like insulin -- especially as drug manufacturers increase their revenues from insulin sales." Sen.Amy Klobuchar
March 19, 2022 Tweet - "A system that allows Americans to pay 250% more for prescription drugs than people in other industrialized nations is just not a system that's working for the American people." Sen.Amy Klobuchar
March 17, 2022 Klobuchar, Colleagues Introduce Legislation to Cap Insulin Costs Sen.Amy Klobuchar
March 17, 2022 Tweet - "Americans pay more for prescription drugs than any other developed country. That is unacceptable. I will never stop fighting to lower prescription drug costs." Sen.Amy Klobuchar
March 16, 2022 Schakowsky, Warren, Klobuchar, Porter, Colleagues Call Out Drug Manufacturers For Providing Misleading Information on High Drug Prices Sen.Amy Klobuchar, ...
March 15, 2022 Tweet - "I'm proud to support capping the price of insulin at $35. Who's with me?" Sen.Amy Klobuchar
March 10, 2022 Tweet - "Remember Joshua from the State of the Union? We need to cap insulin costs at $35 for him." Sen.Amy Klobuchar
March 10, 2022 Letter to Robert Califf, Commissioner of the U.S. Food and Drug Administration - Romney, Durbin Lead Colleagues in Urging FDA to Regulate E-Cigarettes after Six Month Delay Sen.Tina Smith, ...
March 9, 2022 Tweet - "Want to hear something crazy? The average American spends more than $1300/year on prescription drugs. That's more than in any other country in the world. That has to change." Sen.Amy Klobuchar
March 1, 2022 Letter to Stephen J. Ubl, President and CEO of PhRMA - Senator Baldwin, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs Sen.Tina Smith, ...
Feb. 17, 2022 Letter to Hon. Xavier Becerra, Secretary of Health and Human Services, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease, and Dr. Lawrence A. Tabak, Acting Director of the National Institutes of Health - Foster Leads Bipartisan Call to Accelerate Research of COVID-19 Combination Therapies Rep.Angie Craig, ...
Feb. 14, 2022 Letter to Hon. Joseph Biden, President of the United States of America - CONGRESSMAN VALADAO URGES BIDEN TO TAKE ACTION TO COMBAT FENTANYL EPIDEMIC Rep.Pete Stauber, ...
Feb. 12, 2022 Tweet - "We can no longer tolerate policies that make prescription drugs unaffordable and out-of-reach.   Congress must act.   Every day that goes by without implementing meaningful reform is a day too long." Sen.Amy Klobuchar
Feb. 11, 2022 Letter to Joseph R. Biden, President of the United States - Joyce Urges the President to Address Threat of Fentanyl-Related Substances Flooding into American Communities Rep.Michelle Fischbach, ...
Feb. 10, 2022 Emmer Joins 116 Republicans on a Letter Demanding Biden Take Action on Fentanyl Rep.Tom Emmer
Feb. 9, 2022 Tweet - "NOW: @SenSanders and I are speaking on the Senate floor about the urgent need to lower the cost of prescription drugs. Last month alone, drug companies hiked the prices of 742 drugs in the U.S. It is past time for Congress to act." Sen.Amy Klobuchar
Jan. 26, 2022 Tweet - "Still true!" Sen.Amy Klobuchar
Jan. 21, 2022 Tweet - "It's simple: we need to reform the system so Americans can get the drugs they need at prices they can afford." Sen.Amy Klobuchar
Page 2 of 16
arrow_upward